A comprehensive view of GSK Group (GlaxoSmithKline). This page highlights a small sample of our full coverage.
For real-time access, please log in to your Tissue & Hygiene Market Intelligence Service.

Recent Articles

sample of recent headlines, press releases and get more..

'Treatment of EGFR-Driven Cancer with Fewer Side Effects' in Patent Application Approval Process (USPTO 20230146638)
Published: May 26, 2023 by Angiogenesis Daily
Patent Issued for Anti-PD-1 antibodies (USPTO 11643465)
Published: May 25, 2023 by Immunotherapy Daily
Patent Issued for Process for purification of protected polycyclic carbamoylpyridone derivatives (USPTO 11634431)
Published: May 17, 2023 by AIDS Daily
Justices Refuse To Hear ‘Skinny Label’ Drug Patent Case
Published: May 15, 2023 by Well News, The
British Columbia Supreme Court dismisses proposed class action suit alleging GSK's Zantac ranitidine increases the risk of cancer due to lack of reliable evidence; GSK to defend proposed class action suits in Ontario and Quebec
Published: May 12, 2023 by EquityBites

Ask us about our Tissue & Hygiene market view

Trending Chart

Interactive chart with headline count